<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>39(5)</volume><submitter>Rahim A</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To evaluate the role of paracetamol in reducing pain and discomfort during the mammography procedure.&lt;h4>Methods&lt;/h4>This randomized double-blind placebo-controlled trial was conducted at DIR, Ojha and LEJ Campus of DUHS from November 2019 to May 2021. All females aged above 40 years undergoing first time mammogram (screening or diagnostic) were enrolled. Of 639 included participants, 321 were included in paracetamol and 318 in placebo group. Patients in both the groups took medication orally which was customized by the Dow Pharmacy. The degree of pain felt during the mammography procedure was the outcome variable that was measured using Visual Analogue Scale.&lt;h4>Results&lt;/h4>The overall pain was found in 506 (79.19%) women. Pain was significantly higher in women who were</pubmed_abstract><journal>Pakistan journal of medical sciences</journal><pagination>1422-1428</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10480745</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effective strategy to cope the pain and discomfort among women undergoing mammography - A randomized controlled trial.</pubmed_title><pmcid>PMC10480745</pmcid><pubmed_authors>Rahim A</pubmed_authors><pubmed_authors>Rasheed B</pubmed_authors><pubmed_authors>Adil SO</pubmed_authors><pubmed_authors>Aslam N</pubmed_authors><pubmed_authors>Naz N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effective strategy to cope the pain and discomfort among women undergoing mammography - A randomized controlled trial.</name><description>&lt;h4>Objectives&lt;/h4>To evaluate the role of paracetamol in reducing pain and discomfort during the mammography procedure.&lt;h4>Methods&lt;/h4>This randomized double-blind placebo-controlled trial was conducted at DIR, Ojha and LEJ Campus of DUHS from November 2019 to May 2021. All females aged above 40 years undergoing first time mammogram (screening or diagnostic) were enrolled. Of 639 included participants, 321 were included in paracetamol and 318 in placebo group. Patients in both the groups took medication orally which was customized by the Dow Pharmacy. The degree of pain felt during the mammography procedure was the outcome variable that was measured using Visual Analogue Scale.&lt;h4>Results&lt;/h4>The overall pain was found in 506 (79.19%) women. Pain was significantly higher in women who were</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep-Oct</publication><modification>2025-04-22T04:15:45.091Z</modification><creation>2024-12-04T07:33:50.747Z</creation></dates><accession>S-EPMC10480745</accession><cross_references><pubmed>37680791</pubmed><doi>10.12669/pjms.39.5.7500</doi></cross_references></HashMap>